BlackRock’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
551,677
+3,677
+0.7% +$10.7K ﹤0.01% 4255
2025
Q4
$1.75M Buy
548,000
+5,265
+1% +$13.2K ﹤0.01% 4154
2025
Q3
$1.36M Sell
542,735
-2,053
-0.4% -$6.35K ﹤0.01% 4204
2025
Q2
$1.81M Sell
544,788
-28,406
-5% -$101K ﹤0.01% 4093
2025
Q1
$2.4M Sell
573,194
-4,951
-0.9% -$22.5K ﹤0.01% 3935
2024
Q4
$2.79M Buy
578,145
+13,687
+2% +$64.1K ﹤0.01% 3939
2024
Q3
$2.08M Buy
564,458
+8,772
+2% +$31.1K ﹤0.01% 3983
2024
Q2
$2.25M Sell
555,686
-1,188,156
-68% -$5.07M ﹤0.01% 3931
2024
Q1
$8.35M Sell
1,743,842
-35,816
-2% -$208K ﹤0.01% 3442
2023
Q4
$13.5M Buy
1,779,658
+27,492
+2% +$226K ﹤0.01% 3238
2023
Q3
$18M Buy
1,752,166
+57,704
+3% +$712K ﹤0.01% 2997
2023
Q2
$23.4M Sell
1,694,462
-1,757,235
-51% -$26.4M ﹤0.01% 2931
2023
Q1
$56.1M Sell
3,451,697
-21,661
-0.6% -$408K ﹤0.01% 2366
2022
Q4
$61.5M Buy
3,473,358
+170,003
+5% +$3.38M ﹤0.01% 2319
2022
Q3
$64.5M Sell
3,303,355
-92,248
-3% -$1.96M ﹤0.01% 2268
2022
Q2
$67.6M Buy
3,395,603
+57,782
+2% +$1.29M ﹤0.01% 2286
2022
Q1
$86.1M Buy
3,337,821
+47,018
+1% +$1.22M ﹤0.01% 2227
2021
Q4
$83.1M Buy
3,290,803
+205,445
+7% +$5.69M ﹤0.01% 2332
2021
Q3
$82.9M Sell
3,085,358
-39,433
-1% -$1.14M ﹤0.01% 2335
2021
Q2
$99.5M Sell
3,124,791
-92,604
-3% -$2.94M ﹤0.01% 2255
2021
Q1
$113M Buy
3,217,395
+85,724
+3% +$2.98M ﹤0.01% 2123
2020
Q4
$100M Buy
3,131,671
+120,650
+4% +$3.72M ﹤0.01% 2082
2020
Q3
$95.2M Sell
3,011,021
-77,268
-3% -$2.56M ﹤0.01% 1916
2020
Q2
$110M Buy
3,088,289
+10,874
+0.4% +$378K ﹤0.01% 1779
2020
Q1
$88.6M Sell
3,077,415
-136,999
-4% -$3.59M ﹤0.01% 1725
2019
Q4
$75.6M Buy
3,214,414
+95,189
+3% +$2.13M ﹤0.01% 2116
2019
Q3
$56.2M Buy
3,119,225
+38,280
+1% +$632K ﹤0.01% 2226
2019
Q2
$48.3M Sell
3,080,945
-1,282
-0% -$25.2K ﹤0.01% 2336
2019
Q1
$70.2M Buy
3,082,227
+6,080
+0.2% +$137K ﹤0.01% 2087
2018
Q4
$71.5M Buy
3,076,147
+33,290
+1% +$889K ﹤0.01% 2022
2018
Q3
$100M Buy
3,042,857
+125,194
+4% +$4.68M ﹤0.01% 1969
2018
Q2
$129M Buy
2,917,663
+260,789
+10% +$10.1M 0.01% 1776
2018
Q1
$111M Buy
2,656,874
+69,234
+3% +$3.2M 0.01% 1775
2017
Q4
$118M Buy
2,587,640
+40,478
+2% +$1.59M 0.01% 1766
2017
Q3
$84.4M Buy
2,547,162
+81,663
+3% +$3.32M ﹤0.01% 1940
2017
Q2
$100M Sell
2,465,499
-50,161
-2% -$1.55M 0.01% 1799
2017
Q1
$50.7M Buy
2,515,660
+2,514,057
+156,834% +$53.2M ﹤0.01% 2210
2016
Q4
$37K Sell
1,603
-1,642
-51% -$35.2K ﹤0.01% 3062
2016
Q3
$66K Sell
3,245
-164
-5% -$3.31K ﹤0.01% 2833
2016
Q2
$64K Buy
3,409
+1,850
+119% +$34K ﹤0.01% 2810
2016
Q1
$28K Buy
1,559
+959
+160% +$16.4K ﹤0.01% 2673
2015
Q4
$10K Sell
600
-700
-54% -$11.8K ﹤0.01% 2892
2015
Q3
$21K Buy
1,300
+700
+117% +$11.7K ﹤0.01% 2355
2015
Q2
$10K Sell
600
-87
-13% -$1.46K ﹤0.01% 2794
2015
Q1
$11K Hold
687
﹤0.01% 2683
2014
Q4
$10K Hold
687
﹤0.01% 2773
2014
Q3
$10K Hold
687
﹤0.01% 2733
2014
Q2
$10K Hold
687
﹤0.01% 2787
2014
Q1
$10K Hold
687
﹤0.01% 2719
2013
Q4
$12K Hold
687
﹤0.01% 2616
2013
Q3
$11K Hold
687
﹤0.01% 2584
2013
Q2
$8K Buy
+687
New +$8.96K ﹤0.01% 2781

Other funds holding PETS

BlackRock's PETS Position: Q1 2026 in Review

BlackRock increased its PetMed Express (PETS) stake by 0.67% in Q1 2026, buying an estimated $10.7K and bringing the position to 551,677 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4255.

BlackRock first reported a position in PETS in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q2 2018. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • BlackRock held 551,677 shares of PetMed Express worth $1.26M as of Q1 2026.
  • BlackRock bought 3,677 PetMed Express shares in Q1 2026, an estimated $10.7K.
  • PetMed Express made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4255 holding.
  • BlackRock first reported a position in PetMed Express in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's PetMed Express position peaked at $129M in Q2 2018.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.